824 related articles for article (PubMed ID: 9777313)
1. Amphotericin-B colloidal dispersion. A review of its use against systemic fungal infections and visceral leishmaniasis.
Brogden RN; Goa KL; Coukell AJ
Drugs; 1998 Sep; 56(3):365-83. PubMed ID: 9777313
[TBL] [Abstract][Full Text] [Related]
2. Amphotericin B and its new formulations: pharmacologic characteristics, clinical efficacy, and tolerability.
Tiphine M; Letscher-Bru V; Herbrecht R
Transpl Infect Dis; 1999 Dec; 1(4):273-83. PubMed ID: 11428998
[TBL] [Abstract][Full Text] [Related]
3. Liposomal amphotericin B. Therapeutic use in the management of fungal infections and visceral leishmaniasis.
Coukell AJ; Brogden RN
Drugs; 1998 Apr; 55(4):585-612. PubMed ID: 9561346
[TBL] [Abstract][Full Text] [Related]
4. Amphotericin B colloidal dispersion.
Patel R
Expert Opin Pharmacother; 2000 Mar; 1(3):475-88. PubMed ID: 11249532
[TBL] [Abstract][Full Text] [Related]
5. Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections.
Moen MD; Lyseng-Williamson KA; Scott LJ
Drugs; 2009; 69(3):361-92. PubMed ID: 19275278
[TBL] [Abstract][Full Text] [Related]
6. Amphotericin B formulations: a comparative review of efficacy and toxicity.
Hamill RJ
Drugs; 2013 Jun; 73(9):919-34. PubMed ID: 23729001
[TBL] [Abstract][Full Text] [Related]
7. [New lipid formulations of amphotericin B. Review of the literature].
Andrès E; Tiphine M; Letscher-Bru V; Herbrecht R
Rev Med Interne; 2001 Feb; 22(2):141-50. PubMed ID: 11234672
[TBL] [Abstract][Full Text] [Related]
8. Renal impairment and amphotericin B formulations in patients with invasive fungal infections.
Saliba F; Dupont B
Med Mycol; 2008 Mar; 46(2):97-112. PubMed ID: 18324488
[TBL] [Abstract][Full Text] [Related]
9. Optimizing efficacy of amphotericin B through nanomodification.
Vyas SP; Gupta S
Int J Nanomedicine; 2006; 1(4):417-32. PubMed ID: 17722276
[TBL] [Abstract][Full Text] [Related]
10. Amphotericin B colloidal dispersion: an improved antifungal therapy.
Guo LS
Adv Drug Deliv Rev; 2001 Apr; 47(2-3):149-63. PubMed ID: 11311990
[TBL] [Abstract][Full Text] [Related]
11. Amphotericin B colloidal dispersion for the treatment of Indian visceral leishmaniasis.
Sundar S; Mehta H; Chhabra A; Singh V; Chauhan V; Desjeux P; Rai M
Clin Infect Dis; 2006 Mar; 42(5):608-13. PubMed ID: 16447104
[TBL] [Abstract][Full Text] [Related]
12. Lipid-based formulations of amphotericin B.
Veerareddy PR; Vobalaboina V
Drugs Today (Barc); 2004 Feb; 40(2):133-45. PubMed ID: 15045035
[TBL] [Abstract][Full Text] [Related]
13. Randomized, double-blind clinical trial of amphotericin B colloidal dispersion vs. amphotericin B in the empirical treatment of fever and neutropenia.
White MH; Bowden RA; Sandler ES; Graham ML; Noskin GA; Wingard JR; Goldman M; van Burik JA; McCabe A; Lin JS; Gurwith M; Miller CB
Clin Infect Dis; 1998 Aug; 27(2):296-302. PubMed ID: 9709879
[TBL] [Abstract][Full Text] [Related]
14. [Change in human visceral leishmaniasis treatment in Italy: retrospective study of 630 patients].
Gradoni L; Gramiccia M; Scalone A
Parassitologia; 2004 Jun; 46(1-2):199-201. PubMed ID: 15305716
[TBL] [Abstract][Full Text] [Related]
15. Antifungal therapy in infants and children with proven, probable or suspected invasive fungal infections.
Blyth CC; Hale K; Palasanthiran P; O'Brien T; Bennett MH
Cochrane Database Syst Rev; 2010 Feb; 2010(2):CD006343. PubMed ID: 20166083
[TBL] [Abstract][Full Text] [Related]
16. Low-dose amphotericin B lipid complex vs. conventional amphotericin B for empirical antifungal therapy of neutropenic fever in patients with hematologic malignancies--a randomized, controlled trial.
Subirà M; Martino R; Gómez L; Martí JM; Estany C; Sierra J
Eur J Haematol; 2004 May; 72(5):342-7. PubMed ID: 15059069
[TBL] [Abstract][Full Text] [Related]
17. Treatment of invasive fungal infections with amphotericin B colloidal dispersion in bone marrow transplant recipients.
Noskin G; Pietrelli L; Gurwith M; Bowden R
Bone Marrow Transplant; 1999 Apr; 23(7):697-703. PubMed ID: 10218847
[TBL] [Abstract][Full Text] [Related]
18. Treatment of visceral leishmaniasis with amphotericin B colloidal dispersion.
Berman J; Dietze R
Chemotherapy; 1999 Jun; 45 Suppl 1():54-66. PubMed ID: 10394022
[TBL] [Abstract][Full Text] [Related]
19. Use of amphotericin B colloidal dispersion in children.
Sandler ES; Mustafa MM; Tkaczewski I; Graham ML; Morrison VA; Green M; Trigg M; Abboud M; Aquino VM; Gurwith M; Pietrelli L
J Pediatr Hematol Oncol; 2000; 22(3):242-6. PubMed ID: 10864055
[TBL] [Abstract][Full Text] [Related]
20. A double-blind, randomized, controlled trial of amphotericin B colloidal dispersion versus amphotericin B for treatment of invasive aspergillosis in immunocompromised patients.
Bowden R; Chandrasekar P; White MH; Li X; Pietrelli L; Gurwith M; van Burik JA; Laverdiere M; Safrin S; Wingard JR
Clin Infect Dis; 2002 Aug; 35(4):359-66. PubMed ID: 12145716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
